Ablation of Intestinal Metaplasia Containing Dysplasia

Completed · Not applicable · Has a placebo group

Conditions studied: Barrett Esophagus

In brief

The purpose of this study is to determine if the intervention of a 510(k)-cleared endoscopically-guided (Halo Ablation systems), ablation system plus anti-secretory therapy is better than anti-secretory therapy alone in clearing Barrett's Esophagus.

Key facts

Study ID
NCT00282672
Run by
Medtronic - MITG
People needed
127
Starts
2006-02-01
Expected to finish
2014-08-01
Last updated by the study team
2017-11-06

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.